News + Filings Holdings
All
13F
13D/G
Other
|
|
SUVRETTA CAPITAL MANAGEMENT, LLC
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 04/24/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 03/10/2023 |
SC 13G
| SUVRETTA CAPITAL MANAGEMENT, LLC reports a 5.3% stake in KalVista Pharmaceuticals, Inc. |
| 01/03/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 11/02/2022 |
SC 13G
| SUVRETTA CAPITAL MANAGEMENT, LLC reports a 5.6% stake in Biohaven Ltd. |
| 07/21/2022 |
SC 13G
| SUVRETTA CAPITAL MANAGEMENT, LLC reports a 10.2% stake in ProKidney Corp. |
| 06/27/2022 |
SC 13G
| SUVRETTA CAPITAL MANAGEMENT, LLC reports a 5.8% stake in Arcellx, Inc. |
| 06/13/2022 |
SC 13G
| SUVRETTA CAPITAL MANAGEMENT, LLC reports a 5.2% stake in Kezar Life Sciences, Inc. |
| 05/02/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 12/16/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 12/10/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 12/09/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 11/29/2021 |
SC 13G
| SUVRETTA CAPITAL MANAGEMENT, LLC reports a 6% stake in Bolt Biotherapeutics, Inc. |
| 10/15/2021 |
SC 13G
| SUVRETTA CAPITAL MANAGEMENT, LLC reports a 5.2% stake in Gemini Therapeutics, Inc. |
| 09/17/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 08/20/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 08/10/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 07/30/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 07/26/2021 |
SC 13G
| SUVRETTA CAPITAL MANAGEMENT, LLC reports a 5.6% stake in EyePoint Pharmaceuticals, Inc. |
| 05/07/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 04/23/2021 |
SC 13G
| SUVRETTA CAPITAL MANAGEMENT, LLC reports a 7.4% stake in FinTech Acquisition Corp. V |
| 04/22/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 04/02/2021 |
SC 13G
| SUVRETTA CAPITAL MANAGEMENT, LLC reports a 7.8% stake in Therapeutics Acquisition Corp. |
| 03/29/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 03/08/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 03/01/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/26/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/19/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/16/2021 |
SC 13G
| SUVRETTA CAPITAL MANAGEMENT, LLC reports a 5.2% stake in Atlas Crest Investment Corp. |
| 02/16/2021 |
SC 13G
| SUVRETTA CAPITAL MANAGEMENT, LLC reports a 8% stake in Gores Holdings VI, Inc. |
| 02/12/2021 |
SC 13G
| SUVRETTA CAPITAL MANAGEMENT, LLC reports a 2.4% stake in Holicity Inc. |
| 12/21/2020 |
SC 13G
| SUVRETTA CAPITAL MANAGEMENT, LLC reports a 7.8% stake in FinServ Acquisition Corp. |
| 12/18/2020 |
SC 13G
| SUVRETTA CAPITAL MANAGEMENT, LLC reports a 5.8% stake in TPG Pace Beneficial Finance Corp. |
| 11/13/2020 |
SC 13G
| SUVRETTA CAPITAL MANAGEMENT, LLC reports a 5.1% stake in Jaws Acquisition Corp. |
| 11/09/2020 |
SC 13G
| SUVRETTA CAPITAL MANAGEMENT, LLC reports a 7.2% stake in Soleno Therapeutics, Inc. |
|
|
|